Another stellar beat-and-raise quarter didn't launch shares above $200, so there's still time for the well-informed ...
Chicago, IL – March 2, 2026 – Zacks Equity Research shares NVIDIA NVDA as the Bull of the Day and AST SpaceMobile ASTS as the Bear of the Day. In addition, Zacks Equity Research provides analysis on ...
We've spotted a toggle to boot with 16KB page sizes in the Android 17 beta, here's everything you need to know about Google's ...
Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsOliver Gloe - Chief Financial OfficerSean Gadd - President, ...
Operating Expenses -- $22,100,000 for the quarter, compared to $8,900,000, reflecting higher personnel costs for research, ...
The US president has called for regime change following a massive US and Israeli attack, which prompted an unprecedented wave of retaliatory strikes by Iran.
The 2026 municipal budget opened the door to slot machines in city bars and restaurants—but some doubt the benefits outweigh the drawbacks.
As Making Tax Digital for Income Tax (MTD IT) fast approaches, the amount of commentary, speculation, and concern within the profession is intensifying.* ...
In the market for a new dishwasher? Our pros explain all of the must-have features, plus how much you can expect to spend and ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that the Food and Drug Administration (FDA) ...
Drive on MSN
2026 Volvo EX30 Cross Country review
The Cross Country flagship of Volvo’s smallest and fastest-ever production car is a strange ...
Hansa Biopharma AB: PDUFA Action Date for Hansa Biopharma's Imlifidase BLA Set for December 19, 2026
If approved, imlifidase will be the first treatment to address highly sensitized patients awaiting kidney transplantation. LUND, Sweden, March 4, 2026 /PRNewswire/ -- Hansa Biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results